The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Simulation-Guided Rational de Novo Design of a Small Pore-Forming Antimicrobial Peptide
Abstract
In the age of failing small-molecule antibiotics, tapping the near-infinite structural and chemical repertoire of antimicrobial peptides (AMPs) offers one of the most promising routes toward developing next-generation antibacterial compounds. One of the key impediments en route is the lack of methodologies for systematic rational design and optimization of new AMPs. Here we present a new simulation-guided rational design approach and apply it to develop a potent new AMP. We show that unbiased atomic detail molecular dynamics (MD) simulations are able to predict structures formed by evolving peptide designs enabling structure-based rational fine-tuning of functional properties. Starting from a 14-residue poly leucine template we demonstrate the design of a minimalistic potent new AMP. Consisting of only four types of amino acids (LDKA), this peptide forms large pores in microbial membranes at very low peptide-to-lipid ratios (1:1000) and exhibits low micromolar activity against common Gram-positive and Gram-negative pathogenic bacteria. Remarkably, the four amino acids were sufficient to encode preferential poration of bacterial membranes with negligible damage to red blood cells at bactericidal concentrations. As the sequence is too short to span cellular membranes, pores are formed by stacking of channels in each bilayer leaflet.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Lau, J. L., & Dunn, M. K. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.06.052 · Cited by 1,879
Research works printed but not linked: 44
- 10.1073/pnas.84.15.5449 · DOI · Paper page
- 10.1172/JCI114198 · DOI · Paper page
- 10.1124/pr.55.1.2 · DOI · Paper page
- 10.1093/nar/gkv1278 · DOI · Paper page
- 10.1007/s00232-011-9343-0 · DOI · Paper page
- 10.1021/ja500462s · doi:10.1021/ja500462s
- 10.1021/ja3042004 · doi:10.1021/ja3042004
- 10.1021/jacs.5b10595 · DOI
- 10.1021/jacs.8b03026 · doi:10.1021/jacs.8b03026
- 10.1016/j.bbamem.2014.12.023 · DOI
- 10.1021/jacs.6b11447 · DOI
- 10.1038/ncomms13535 · DOI
- 10.1021/ja204042f · DOI
- 10.1016/j.bpj.2013.02.006 · doi:10.1016/j.bpj.2013.02.006
- 10.1016/j.bbamem.2014.04.012 · doi:10.1016/j.bbamem.2014.04.012
- 10.1038/ncomms5863 · DOI
- 10.1016/j.bbamem.2014.04.009 · doi:10.1016/j.bbamem.2014.04.009
- 10.1002/chem.201601765 · DOI
- 10.1021/acs.accounts.7b00613 · DOI · Paper page
- 10.1021/ct800100m · DOI
- 10.1021/ja909347x · DOI
- 10.1093/nar/gkl164 · DOI · Paper page
- 10.1021/ja305644e · DOI · Paper page
- 10.1038/s41467-018-03746-3 · DOI · Paper page
- 10.1073/pnas.0900638106 · DOI
- 10.1021/jp212358y · DOI
- 10.1016/j.bpj.2013.01.059 · doi:10.1016/j.bpj.2013.01.059
- 10.1038/nsb1096-842 · DOI · Paper page
- 10.1146/annurev.biophys.28.1.319 · DOI · Paper page
- 10.1016/j.sbi.2014.05.003 · DOI
- 10.1074/jbc.M115.656769 · doi:10.1074/jbc.m115.656769
- 10.1002/psc.60 · doi:10.1002/psc.60
- 10.1071/C97059 · doi:10.1071/c97059
- 10.1002/rcm.429 · doi:10.1002/rcm.429
- 10.1074/jbc.M310838200 · DOI
- 10.1002/rcm.3723 · DOI
- 10.1021/pr200393t · DOI
- 10.1046/j.1432-1327.2000.01536.x · DOI · Paper page
- 10.1086/429523 · DOI · Paper page
- 10.1016/j.bpj.2017.06.070 · DOI
- 10.1016/j.bbamem.2015.06.013 · doi:10.1016/j.bbamem.2015.06.013
- 10.1038/s42003-018-0224-2 · DOI · Paper page
- 10.1038/s41467-018-04874-6 · DOI
- 10.1021/bi020244r · doi:10.1021/bi020244r
Cited by
Development and Challenges of Antimicrobial Peptides for Therapeutic Applications
Chen, C. H., & Lu, T. K. (2020) · Antibiotics · doi:10.3390/antibiotics9010024 · Cited by 598
Self-citationAccelerated antimicrobial discovery via deep generative models and molecular dynamics simulations
Das, P., Sercu, T., Wadhawan, K., Padhi, I., Gehrmann, S., Cipcigan, F., Chenthamarakshan, V., Strobelt, H., dos Santos, C., Chen, P.-Y., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00689-x · Cited by 414
Antimicrobial Peptides: An Update on Classifications and Databases
Bin Hafeez, A., Jiang, X., Bergen, P. J., & Zhu, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111691 · Cited by 341
Chemical syntheses of bioinspired and biomimetic polymers toward biobased materials
Ganewatta, M. S., Wang, Z., & Tang, C. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00325-x · Cited by 290
Huang, J., Xu, Y., Xue, Y., Huang, Y., Li, X., Chen, X., Xu, Y., Zhang, D., Zhang, P., Zhao, J., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00991-2 · Cited by 270
Metadata
- Authors
- Chen, C. H., Starr, C. G., Troendle, E., Wiedman, G., Wimley, W. C., Ulmschneider, J. P., & Ulmschneider, M. B.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-03-06
- Volume
- 141
- Issue
- 12
- Pages
- 4839-4848
- ISSN
- 0002-7863
- 1520-5126
- Cited by
- 127
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.